Form 4: Abbott Laboratories Executive Vice President Lisa D. Earnhardt Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President of Abbott Laboratories, Lisa D. Earnhardt, reports the disposition and acquisition of company stock.
Summary
- Lisa D. Earnhardt, an Executive Vice President at Abbott Laboratories, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- On February 29, 2024, 7,669 common shares were disposed of at a price of $120.05.
- On March 1, 2024, 694 common shares were disposed of at a price of $118.5.
- Following these transactions, Earnhardt directly owns 84,314 common shares of Abbott Laboratories.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The reported transactions may be of interest to shareholders as they provide insight into the actions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 02/29/2024 | Disposition of 7,669 common shares at $120.05. |
| 03/01/2024 | Disposition of 694 common shares at $118.5. |
| 03/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.